Results 61 to 70 of about 2,901,103 (137)

CA 15-3 [PDF]

, 2019
openaire   +2 more sources

Cáncer de mama en una paciente de 21 años

Medisan, 2016
Se presenta el caso clínico de una paciente de 21 años de edad, quien acudió a la consulta de Oncología del Hospital Gubernamental de Mbabane en Suazilandia por presentar un nódulo en la mama derecha con manifestaciones de dolor intenso desde hacía 1 mes.
Ernesto Arias Beatón, Martha Beatriz Arias Beatón, Yoryana Elena Tellería León, Yosvanis Causa Torres   +3 more
doaj  

Associations of serum CA 15-3 with interstitial lung disease, PM/Scl100 antibodies and other disease characteristics in systemic sclerosis. [PDF]

Sci Rep
Trefler J, Pasierb A, Lech L, Życińska K.   +3 more
europepmc   +1 more source

Falsely Elevated CA 15-3 Levels in Ovarian Sarcoidosis with Peritoneal Involvement and Ascites. [PDF]

Case Rep Obstet Gynecol, 2018
Tsiodras S, Gouloumi AR, Tsakiraki Z, Chrelias G, Chrelias C, Loukides S, Panayiotides I.   +6 more
europepmc   +1 more source

Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia. [PDF]

Saudi Med J
Ashi A, Al-Hajeili M, Almaghrabi S, Al-Maghrabi J, Trabulsi N, Alghuraibi S, Alsiary R, Alrayes N.   +7 more
europepmc   +1 more source

Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery. [PDF]

Ecancermedicalscience, 2019
Buonomo B, Noli SA, Santini A, Alviggi C, Peccatori FA.   +4 more
europepmc   +1 more source

Salivary Transmembrane Mucins of the MUC1 Family (CA 15-3, CA 27.29, MCA) in Breast Cancer: The Effect of Human Epidermal Growth Factor Receptor 2 (HER2). [PDF]

Cancers (Basel)
Dyachenko EI, Bel'skaya LV.
europepmc   +1 more source

Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA. [PDF]

Oncotarget, 2018
Zaleski M, Kobilay M, Schroeder L, Debald M, Semaan A, Hettwer K, Uhlig S, Kuhn W, Hartmann G, Holdenrieder S.   +9 more
europepmc   +1 more source

Sensing CA 15-3 in point-of-care by electropolymerizing O-phenylenediamine (oPDA) on Au-screen printed electrodes. [PDF]

PLoS One, 2018
Gomes RS, Moreira FTC, Fernandes R, Sales MGF.   +3 more
europepmc   +1 more source

Hypermetabolic Pulmonary and Mediastinal Lesions With Elevated Cancer Antigen (CA) 15-3 and CA 27-29 in a Patient With a History of Ovarian and Breast Cancer. [PDF]

Cureus
Venkatram S, Duran M, Fortuzi K, Baqui A, Luong TH, Diaz-Fuentes G.   +5 more
europepmc   +1 more source